|
AU2016253580A1
|
|
Injection Needle and Device
|
|
EP3046936A1
|
|
Treatment of hepatitis d virus infections by redirection of t cells
|
|
US2016324954A1
|
|
Immunogenic compositions for inhibiting hepatitis d virus
|
|
WO2014064534A2
|
|
Injection needle, device, immunogenic compositions and method of use
|
|
AU2012270015A1
|
|
Injection needle and device
|
|
WO2011073796A2
|
|
Codon-optimzed hepatitis b virus core antigen (hbcag)
|
|
EP2504358A2
|
|
T cell receptors specific for immunodominant ctl epitopes of hcv
|
|
WO2010086743A2
|
|
Codon-optimised hepatitis b virus core antigen
|
|
US2009215869A1
|
|
Hepatitis C virus non-structural NS3/4A fusion gene
|
